Temple R - Search Results

1

Issues in regulatory guidelines for data monitoring committees.

DeMets D, Califf R, Dixon D, Ellenberg S, Fleming T, Held P, Julian D, Kaplan R, Levine R, Neaton J, Packer M, Pocock S, Rockhold F, Seto B, Siegel J, Snapinn S, Stump D, Temple R, Whitley R. DeMets D, et al. Among authors: temple r. Clin Trials. 2004;1(2):162-9. doi: 10.1191/1740774504cn019xx. Clin Trials. 2004. PMID: 16281888 Review.

2

Sensible guidelines for the conduct of large randomized trials.

Yusuf S, Bosch J, Devereaux PJ, Collins R, Baigent C, Granger C, Califf R, Temple R. Yusuf S, et al. Among authors: temple r. Clin Trials. 2008;5(1):38-9. doi: 10.1177/1740774507088099. Clin Trials. 2008. PMID: 18283078 No abstract available.

3

Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: practical issues and specific cases.

Ellenberg SS, Temple R. Ellenberg SS, et al. Among authors: temple r. Ann Intern Med. 2000 Sep 19;133(6):464-70. doi: 10.7326/0003-4819-133-6-200009190-00015. Ann Intern Med. 2000. PMID: 10975965 Free article.

4

Independent data monitoring committees: preparing a path for the future.

Hess CN, Roe MT, Gibson CM, Temple RJ, Pencina MJ, Zarin DA, Anstrom KJ, Alexander JH, Sherman RE, Fiedorek FT, Mahaffey KW, Lee KL, Chow SC, Armstrong PW, Califf RM. Hess CN, et al. Am Heart J. 2014 Aug;168(2):135-41.e1. doi: 10.1016/j.ahj.2014.05.003. Epub 2014 May 15. Am Heart J. 2014. PMID: 25066551 Free PMC article.

5

Independence of the statistician who analyses unblinded data.

Siegel JP, O'Neill RT, Temple R, Campbell G, Foulkes MA. Siegel JP, et al. Among authors: temple r. Stat Med. 2004 May 30;23(10):1527-9. doi: 10.1002/sim.1789. Stat Med. 2004. PMID: 15122732

6

Panel discussion 2.

Ellenberg S, Luce B, Fleming T, Siegel J, Strom B, Hernán M, Temple R, Sackett D, Bourguignon C, Bekelman J, Berry D, Rotelli M, Judkins D, Schwartz S, Goodman S. Ellenberg S, et al. Among authors: temple r. Clin Trials. 2012 Feb;9(1):66-79. doi: 10.1177/1740774511433048. Clin Trials. 2012. PMID: 22334467 No abstract available.

7

Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues.

Temple R, Ellenberg SS. Temple R, et al. Ann Intern Med. 2000 Sep 19;133(6):455-63. doi: 10.7326/0003-4819-133-6-200009190-00014. Ann Intern Med. 2000. PMID: 10975964 Free article.

8

Remembering Dr Ray Lipicky.

Califf RM, Temple R. Califf RM, et al. Among authors: temple r. Circulation. 2018 Mar 27;137(13):1309. doi: 10.1161/CIRCULATIONAHA.118.034595. Circulation. 2018. PMID: 29581359 No abstract available.

9

Homocysteine as a predictive factor for hip fracture in older persons.

Ellenberg SS, Orloff DG, Temple RJ. Ellenberg SS, et al. N Engl J Med. 2004 Sep 2;351(10):1027-30; author reply 1027-30. N Engl J Med. 2004. PMID: 15352276 No abstract available.

10

Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and regulatory issues.

Jolicoeur EM, Ohman EM, Temple R, Stockbridge N, Smith S, Mark D, Califf RM, Henry TD, Chaitman BR, Granger CB; Working Group Members. Jolicoeur EM, et al. Among authors: temple r. Am Heart J. 2008 Mar;155(3):435-44. doi: 10.1016/j.ahj.2007.12.005. Epub 2008 Jan 31. Am Heart J. 2008. PMID: 18294475 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

329 results

Search Page

Filters